Share Facebook Twitter LinkedIn Pinterest Email Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization
Solana Company expects first validator-related rewards in Q3 2026 as 0.5 million SOL stake commitment supports Tokyo cluster (NASDAQ:HSDT)August 15, 2026